- Home
- PCRX vs ARHS Comparison
PCRX vs ARHS Comparison
Compare PCRX & ARHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCRX
- ARHS
- Stock Information
- Founded
- PCRX 2006
- ARHS 1986
- Country
- PCRX United States
- ARHS United States
- Employees
- PCRX N/A
- ARHS N/A
- Industry
- PCRX Biotechnology: Pharmaceutical Preparations
- ARHS Other Specialty Stores
- Sector
- PCRX Health Care
- ARHS Consumer Discretionary
- Exchange
- PCRX Nasdaq
- ARHS Nasdaq
- Market Cap
- PCRX 1.2B
- ARHS 1.1B
- IPO Year
- PCRX 2011
- ARHS 2021
- Fundamental
- Price
- PCRX $26.29
- ARHS $8.60
- Analyst Decision
- PCRX Buy
- ARHS Buy
- Analyst Count
- PCRX 9
- ARHS 13
- Target Price
- PCRX $29.89
- ARHS $11.08
- AVG Volume (30 Days)
- PCRX 891.6K
- ARHS 2.0M
- Earning Date
- PCRX 05-08-2025
- ARHS 05-08-2025
- Dividend Yield
- PCRX N/A
- ARHS N/A
- EPS Growth
- PCRX N/A
- ARHS N/A
- EPS
- PCRX N/A
- ARHS 0.41
- Revenue
- PCRX $702,772,000.00
- ARHS $1,287,317,000.00
- Revenue This Year
- PCRX $8.63
- ARHS $7.07
- Revenue Next Year
- PCRX $11.66
- ARHS $7.71
- P/E Ratio
- PCRX N/A
- ARHS $21.91
- Revenue Growth
- PCRX 3.08
- ARHS 0.71
- 52 Week Low
- PCRX $11.16
- ARHS $6.61
- 52 Week High
- PCRX $31.64
- ARHS $19.81
- Technical
- Relative Strength Index (RSI)
- PCRX 49.37
- ARHS 52.99
- Support Level
- PCRX $25.33
- ARHS $8.53
- Resistance Level
- PCRX $26.44
- ARHS $9.05
- Average True Range (ATR)
- PCRX 0.91
- ARHS 0.39
- MACD
- PCRX -0.03
- ARHS 0.06
- Stochastic Oscillator
- PCRX 61.96
- ARHS 65.32
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.
About ARHS Arhaus Inc.
Arhaus Inc is a growing lifestyle brand and omnichannel retailer of premium home furniture. The company offers merchandise in several categories, including furniture, outdoor, lighting, textiles, and decor through its Retail and e-commerce sales channels.